The Molecular Quality Controls Market is witnessing strong momentum as molecular diagnostics continue to transform modern healthcare. Molecular quality controls are essential tools used to validate and monitor the accuracy, precision, and reliability of molecular diagnostic tests, including PCR, next-generation sequencing (NGS), and infectious disease testing. As healthcare systems worldwide increasingly rely on molecular testing for early disease detection and precision medicine, the demand for robust quality control solutions is rising significantly.

The molecular quality controls market size is projected to reach US$ 0.52 billion by 2031 from US$ 0.22 billion in 2023, registering a CAGR of 12.8% during 2023–2031. This rapid growth reflects the expanding adoption of molecular diagnostics, rising regulatory scrutiny, and the need for consistent laboratory performance across clinical and research settings.

Download Sample PDF Copy:
https://www.theinsightpartners.com/sample/TIPRE00005166

Market Drivers

Rapid Expansion of Molecular Diagnostics

One of the primary drivers of the molecular quality controls market is the accelerating adoption of molecular diagnostic technologies. Techniques such as PCR, real-time PCR, digital PCR, and NGS have become indispensable for detecting infectious diseases, genetic disorders, oncology biomarkers, and inherited conditions.

The global pandemic significantly accelerated the adoption of molecular testing, particularly RT-PCR, which highlighted the importance of quality assurance in laboratory testing. This surge in testing exposed the need for validated and standardized quality control materials to ensure reliable diagnostic results. Even post-pandemic, laboratories continue to expand molecular testing capacity, sustaining long-term demand for quality control solutions.

Increasing Prevalence of Infectious and Chronic Diseases

The rising burden of infectious diseases such as tuberculosis, hepatitis, HIV, influenza, and emerging viral infections is fueling the demand for molecular diagnostic testing. Simultaneously, chronic diseases including cancer and genetic disorders require molecular testing for accurate diagnosis and treatment monitoring.

Molecular quality controls play a crucial role in ensuring the accuracy of these diagnostic tests. As testing volumes increase globally, laboratories must maintain stringent quality standards, creating a continuous demand for external and internal molecular quality control materials.

Growing Adoption of Personalized Medicine

Precision medicine is transforming patient care by enabling tailored treatment based on genetic and molecular profiles. Molecular diagnostics serve as the backbone of personalized medicine, particularly in oncology, rare diseases, and pharmacogenomics.

However, personalized medicine relies heavily on the reliability of molecular testing. Even minor testing inaccuracies can lead to incorrect treatment decisions. As a result, healthcare providers and laboratories are investing heavily in molecular quality controls to ensure the accuracy of complex genomic testing workflows.

Rising Regulatory and Accreditation Requirements

Stringent regulatory frameworks and accreditation standards are significantly driving the molecular quality controls market. Regulatory bodies and laboratory accreditation organizations require clinical laboratories to implement strict quality management systems.

Quality control materials help laboratories comply with international standards and regulatory requirements by validating testing processes, monitoring assay performance, and ensuring reproducibility. As regulatory oversight continues to increase globally, the demand for high-quality control solutions is expected to grow steadily.

Increasing Number of Diagnostic Laboratories

The rapid growth of diagnostic laboratories worldwide, particularly in emerging economies, is another key market driver. Governments and private healthcare providers are investing heavily in diagnostic infrastructure to improve access to healthcare services.

As new laboratories are established and existing facilities expand molecular testing capabilities, the need for standardized quality control materials becomes essential. This trend is especially prominent in developing regions where healthcare systems are strengthening diagnostic capabilities.

Technological Advancements in Quality Control Products

Technological innovation is enabling the development of advanced molecular quality control materials that closely mimic patient samples. These products offer enhanced stability, longer shelf life, and compatibility with multiple diagnostic platforms.

Multiplex controls, third-party controls, and synthetic controls are gaining popularity as laboratories seek flexible and cost-effective solutions. These advancements are making quality control workflows more efficient and reliable, further boosting market growth.

Market Trends

Increasing Demand for Third-Party Controls

Third-party molecular controls are gaining traction as laboratories seek independent validation of diagnostic tests. These controls help detect assay variability and ensure unbiased test performance across platforms.

Automation and Digital Integration in Laboratories

Automation in molecular laboratories is increasing, leading to the need for automated quality control workflows. Integrated quality management systems are helping laboratories streamline operations and maintain consistent performance.

Growth of Companion Diagnostics

Companion diagnostics used in targeted therapies require stringent quality control measures. The rise of targeted cancer therapies is creating new opportunities for molecular quality control manufacturers.

Market Segmentation Overview

By Product Type

• Independent Controls
• Instrument-Specific Controls

By Application

• Infectious Diseases
• Oncology
• Genetic Testing
• Others

By End User

• Clinical Laboratories
• Hospitals
• Research Institutes
• Diagnostic Centers

Clinical laboratories represent the largest market share due to the high volume of molecular testing conducted daily.

Regional Analysis

North America

North America dominates the molecular quality controls market due to advanced healthcare infrastructure, strong regulatory frameworks, and widespread adoption of molecular diagnostics. The presence of major diagnostic companies and high healthcare spending further strengthens the region’s leadership.

Europe

Europe represents a significant market driven by strict regulatory requirements and increasing adoption of precision medicine. Government initiatives supporting advanced diagnostics are boosting market growth.

Asia-Pacific

The Asia-Pacific region is expected to witness the fastest growth during the forecast period. Rising healthcare investments, expanding diagnostic infrastructure, and increasing awareness of molecular testing are key growth drivers in countries such as China and India.

Rest of the World

Emerging economies in Latin America, the Middle East, and Africa are gradually adopting molecular diagnostics, creating new growth opportunities for quality control providers.

Competitive Landscape and Key Players

The molecular quality controls market is moderately competitive, with companies focusing on product innovation, partnerships, and geographic expansion. Key players include:

• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd
• QIAGEN N.V.
• ZeptoMetrix Corporation
• SeraCare Life Sciences
• Microbiologics, Inc.
• LGC Group
• Randox Laboratories Ltd
• Abbott Laboratories

These companies are investing heavily in R&D to develop innovative and platform-compatible quality control products.

Future Outlook

The molecular quality controls market is poised for strong growth through 2031. The convergence of precision medicine, increasing molecular testing volumes, regulatory pressures, and technological advancements will continue to drive demand.

As laboratories strive to maintain accuracy, consistency, and compliance, molecular quality controls will remain an indispensable component of modern diagnostics.

About Us

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us

Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish